LATOBS:AQUISEUInvestment AB Latour Class B Analysis
Data as of 2026-03-14 - not real-time
SEK 202.70
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Investment AB Latour is trading at its 52‑week low, aligning closely with a key technical support level while technical indicators point to a bearish short‑term outlook – the 20‑day SMA sits below the price, the 14‑day RSI is deep in oversold territory, and the MACD histogram remains negative.
Despite the price pressure, the company posted a record Q4 with a strong operating margin and robust free cash flow, supporting a sustainable dividend yield around 2.3%. The DCF model suggests a fair value notably below the current market price, indicating a potential overvaluation in the near term, but the solid balance sheet, modest debt‑to‑equity ratio for an industrial conglomerate, and consistent dividend payouts provide a defensive cushion for longer horizons.
Despite the price pressure, the company posted a record Q4 with a strong operating margin and robust free cash flow, supporting a sustainable dividend yield around 2.3%. The DCF model suggests a fair value notably below the current market price, indicating a potential overvaluation in the near term, but the solid balance sheet, modest debt‑to‑equity ratio for an industrial conglomerate, and consistent dividend payouts provide a defensive cushion for longer horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price at technical support with bearish momentum
- RSI indicating oversold conditions
- Increasing volume suggesting potential short‑term bounce
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Current price above DCF fair value
- Strong dividend yield and payout ratio under 60%
- Stable operating margins and cash flow generation
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable dividend and solid free cash flow
- Long‑term strategic focus on steady‑growth investee companies
- Potential price correction aligning market price with intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth5.70%
Profit Margin17.47%
P/E Ratio26.5
ROE11.41%
ROA3.33%
Debt/Equity45.06
P/B Ratio3.0
Op. Cash FlowSEK3.7B
Free Cash FlowSEK8.0B
Industry P/E29.1
Technical Analysis
TrendBearish
RSI20.3
SupportSEK 202.70
ResistanceSEK 230.60
MA 20SEK 217.77
MA 50SEK 222.16
MA 200SEK 239.93
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueSEK 187.71
GradeOvervalued
TypeBlend
Dividend Yield2.27%
Risk Assessment
Beta0.27
Volatility28.71%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.